RTH ß |
Most commonly a mutation or deletion in ligand binding domain of TRβ, generally producing reduced ligand binding and irreversible interaction with corepressors |
In most cases resistance to thyroid hormone feedback at the pituitary (mediated by TRβ) |
Goiter |
Enhanced metabolic rate |
28, 178, 202
|
Elevated serum T4 and T3, “inappropriately” normal range serum TSH |
Generally euthyroid, except for tachycardia (unopposed action of the elevated serum T4 and T3 stimulating TRα in the atria) |
Hyperphagia |
Elevated T4/T3 “compensate” for resistance to thyroid hormone |
In some models; reduced linear growth, impaired hearing, defects in bone formation, and attention deficit disorder |
|
RTH α |
In the few reported cases, a mutation in ligand binding domain of TRα, analogous to those found in TRβ, generally producing reduced ligand binding and irreversible interaction with corepressors |
Pituitary is predominantly TRβ, pituitary normally sensitive to feedback |
Short stature |
Elevated cholesterol |
21, 258
|
Normal T4, T3, and TSH |
Developmental delay |
Elevated BMI |
Elevated serum T3/T4 ratio compared with normal |
Bony deformities |
Chronic constipation |